Journal Information

Statistics

Follow this link to access the full text of the article

Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008; 14(6):803–827
Araújo A, et al. Avaliação económica do erlotinib, docetaxel, pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulmão de não pequenas células Rev Port Pneumol 2008; 14(6):803–827
Wojciech Bartminski
European Outcomes Research, Health Outcomes Scientist, Oncology & Neuroscience, EMS AREA
Read
889
Times
was read the article
480
Total PDF
409
Total HTML
Share statistics
Article information
ISSN: 21735115
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 28 32 60
2024 October 23 29 52
2024 September 28 28 56
2024 August 49 34 83
2024 July 25 25 50
2024 June 19 21 40
2024 May 21 37 58
2024 April 22 17 39
2024 March 20 14 34
2024 February 18 23 41
2024 January 17 28 45
2023 December 13 14 27
2023 November 22 29 51
2023 October 12 30 42
2023 September 15 28 43
2023 August 23 25 48
2023 July 18 27 45
2023 June 13 8 21
2023 May 18 24 42
2023 April 5 7 12
Show all

Follow this link to access the full text of the article

Pulmonology

Are you a health professional able to prescribe or dispense drugs?